Sell Gold for Bitcoin? (and This?)
It’s a controversial call.

But former Wall Street VP and hedge fund manager Teeka Tiwari says he “no longer expects gold to adequately protect your wealth against the money printing happening right now.”

And for the first time in Palm Beach Research Group history, an editor is telling readers to sell gold… and buy Bitcoin.
But this is about more than just one coin…

ANVS Insider Trading (Annovis Bio)

Insider Ownership Percentage: 42.60%
Insider Buying (Last 12 Months): $520,791.46
Insider Selling (Last 12 Months): $0.00

Annovis Bio Insider Trading History Chart

This chart shows the insider buying and selling history at Annovis Bio by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Annovis Bio Share Price & Price History

Current Price: $28.89
Price Change: Price Decrease of -0.5 (-1.70%)
As of 10/22/2021 05:00 PM ET

This chart shows the closing price history over time for ANVS up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Former Tech Executive Issues Urgent Plea
"I'm not trying to scare you...

But for many people - life is about to take a very strange turn."
Click to Hear His New Warning.

Annovis Bio Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/11/2021Claudine BruckDirectorBuy181$27.66$5,006.46View SEC Filing Icon  
10/11/2021Maria-Luisa MaccecchiniCEOBuy18,000$27.61$496,980.00View SEC Filing Icon  
8/19/2021Reid MccarthyDirectorBuy500$37.61$18,805.006,829View SEC Filing Icon  
See Full Table
Insider Trading at Annovis Bio?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Annovis Bio and related companies.

SEC Filings (Institutional Ownership Changes) for Annovis Bio (NYSE:ANVS)

15.60% of Annovis Bio stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ANVS by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Annovis Bio Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
10/21/2021Essex LLC11,962$0.38M0.1%N/A0.148%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC17,442$1.49M0.1%+119.4%0.215%Search for SEC Filing on Google Icon
9/3/2021Parametric Portfolio Associates LLC22,331$1.91M0.0%N/A0.276%Search for SEC Filing on Google Icon
8/23/2021Morgan Stanley30,070$2.57M0.0%N/A0.371%Search for SEC Filing on Google Icon
8/18/2021Ikarian Capital LLC103,527$8.86M0.7%-46.5%1.278%Search for SEC Filing on Google Icon
8/17/2021Wells Fargo & Company MN537$47K0.0%+2,048.0%0.007%Search for SEC Filing on Google Icon
8/17/2021Worth Venture Partners LLC33,834$2.90M1.1%+12.9%0.418%Search for SEC Filing on Google Icon
8/17/2021Knoll Capital Management LLC39,210$3.36M1.8%N/A0.484%Search for SEC Filing on Google Icon
8/17/2021Millennium Management LLC3,587$0.31M0.0%N/A0.044%Search for SEC Filing on Google Icon
8/17/2021Price T Rowe Associates Inc. MD3,000$0.26M0.0%N/A0.037%Search for SEC Filing on Google Icon
8/17/2021Boothbay Fund Management LLC11,756$1.01M0.0%-46.5%0.145%Search for SEC Filing on Google Icon
8/17/2021Bridgeway Capital Management LLC23,600$2.02M0.0%+4.9%0.291%Search for SEC Filing on Google Icon
8/16/2021Cubist Systematic Strategies LLC4,508$0.39M0.0%N/A0.056%Search for SEC Filing on Google Icon
8/16/2021Morgan Stanley30,070$2.57M0.0%N/A0.371%Search for SEC Filing on Google Icon
8/16/2021Diametric Capital LP12,458$1.07M0.8%-26.0%0.154%Search for SEC Filing on Google Icon
8/16/2021State Street Corp17,300$1.48M0.0%N/A0.214%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.25,819$2.21M0.0%N/A0.319%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp9,098$0.78M0.0%+22.5%0.112%Search for SEC Filing on Google Icon
8/13/2021RKL Wealth Management LLC5,000$0.43M0.1%-50.0%0.062%Search for SEC Filing on Google Icon
8/13/2021Wealthspire Advisors LLC5,000$0.43M0.0%-50.0%0.062%Search for SEC Filing on Google Icon
8/13/2021LPL Financial LLC3,868$0.33M0.0%N/A0.048%Search for SEC Filing on Google Icon
8/13/2021Geode Capital Management LLC38,569$3.30M0.0%+39.8%0.476%Search for SEC Filing on Google Icon
8/13/2021Vanguard Group Inc.229,453$19.64M0.0%+56.1%2.832%Search for SEC Filing on Google Icon
8/13/2021EAM Global Investors LLC29,590$2.53M0.7%N/A0.365%Search for SEC Filing on Google Icon
8/13/2021EAM Investors LLC48,643$4.16M0.6%+9.0%0.600%Search for SEC Filing on Google Icon
8/12/2021AIGH Capital Management LLC126,469$10.82M1.9%+7.9%1.561%Search for SEC Filing on Google Icon
8/12/2021JPMorgan Chase & Co.8,024$0.69M0.0%N/A0.099%Search for SEC Filing on Google Icon
8/12/2021L & S Advisors Inc19,530$1.67M0.2%N/A0.241%Search for SEC Filing on Google Icon
8/11/2021Commonwealth Equity Services LLC3,964$0.34M0.0%N/A0.049%Search for SEC Filing on Google Icon
8/11/2021Bank of New York Mellon Corp22,168$1.90M0.0%N/A0.274%Search for SEC Filing on Google Icon
8/11/2021BlackRock Inc.100,997$8.64M0.0%N/A1.247%Search for SEC Filing on Google Icon
8/11/2021Deutsche Bank AG4,367$0.37M0.0%N/A0.054%Search for SEC Filing on Google Icon
8/11/2021Redmond Asset Management LLC7,750$0.66M0.2%N/A0.096%Search for SEC Filing on Google Icon
8/10/2021Virtus ETF Advisers LLC2,518$0.22M0.1%N/A0.031%Search for SEC Filing on Google Icon
8/10/2021National Asset Management Inc.2,430$0.21M0.0%N/A0.030%Search for SEC Filing on Google Icon
8/9/2021Broderick Brian C4,000$0.34M0.1%N/A0.049%Search for SEC Filing on Google Icon
8/9/2021Cannell Peter B & Co. Inc.16,000$1.37M0.0%+60.0%0.198%Search for SEC Filing on Google Icon
8/6/2021Sei Investments Co.15,244$1.31M0.0%N/A0.188%Search for SEC Filing on Google Icon
8/5/2021US Bancorp DE500$43K0.0%N/A0.006%Search for SEC Filing on Google Icon
8/3/2021Absher Wealth Management LLC6,329$0.54M0.1%N/A0.078%Search for SEC Filing on Google Icon
8/2/2021Advisor Group Holdings Inc.1,742$0.15M0.0%-58.5%0.022%Search for SEC Filing on Google Icon
8/2/2021Modera Wealth Management LLC34,746$2.97M0.2%-14.5%0.429%Search for SEC Filing on Google Icon
7/31/2021Sterling Investment Advisors Ltd.20,574$1.76M0.5%-35.1%0.254%Search for SEC Filing on Google Icon
6/10/2021Lokken Investment Group LLC17,411$0.49M0.4%-45.9%0.251%Search for SEC Filing on Google Icon
5/19/2021Virtu Financial LLC7,951$0.22M0.0%N/A0.114%Search for SEC Filing on Google Icon
5/19/2021Worth Venture Partners LLC29,968$0.84M0.4%-74.9%0.431%Search for SEC Filing on Google Icon
5/19/2021Diametric Capital LP16,837$0.47M0.4%N/A0.242%Search for SEC Filing on Google Icon
5/18/2021Citadel Advisors LLC8,963$0.25M0.0%N/A0.129%Search for SEC Filing on Google Icon
5/17/2021Ikarian Capital LLC193,368$5.40M0.2%N/A2.783%Search for SEC Filing on Google Icon
5/14/2021Brown Advisory Inc.7,442$0.21M0.0%-50.2%0.107%Search for SEC Filing on Google Icon
5/13/2021Renaissance Technologies LLC19,900$0.56M0.0%N/A0.286%Search for SEC Filing on Google Icon
5/12/2021Northern Trust Corp7,425$0.21M0.0%N/A0.107%Search for SEC Filing on Google Icon
5/12/2021Geode Capital Management LLC27,583$0.77M0.0%N/A0.397%Search for SEC Filing on Google Icon
5/11/2021EAM Investors LLC44,640$1.25M0.2%N/A0.643%Search for SEC Filing on Google Icon
5/10/2021RKL Wealth Management LLC10,000$0.28M0.0%N/A0.144%Search for SEC Filing on Google Icon
5/4/2021Sterling Investment Advisors Ltd.31,678$0.88M0.3%-37.4%0.456%Search for SEC Filing on Google Icon
4/23/2021BRYN MAWR TRUST Co14,643$0.41M0.0%N/A0.211%Search for SEC Filing on Google Icon
2/11/2021Modera Wealth Management LLC43,846$0.33M0.0%N/A0.635%Search for SEC Filing on Google Icon
2/8/2021Lokken Investment Group LLC32,211$0.24M0.2%N/A0.466%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Annovis Bio logo
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is ANVS401, which is in Phase 2a clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, Alzheimer's disease in Down Syndrome, and other chronic neurodegenerative disorders. It is also developing ANVS405 for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.
Read More on Annovis Bio

Today's Range

Now: $28.89
Low: $28.02
High: $29.24

50 Day Range

MA: $33.95
Low: $25.67
High: $41.82

52 Week Range

Now: $28.89
Low: $4.14
High: $132.00

Volume

67,163 shs

Average Volume

715,122 shs

Market Capitalization

$234.04 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.17

Who are the company insiders with the largest holdings of Annovis Bio?

Annovis Bio's top insider investors include:
  1. Reid Mccarthy (Director)
  2. Claudine Bruck (Director)
  3. Maria-Luisa Maccecchini (CEO)

Who are the major institutional investors of Annovis Bio?

Annovis Bio's top institutional shareholders include:
  1. Essex LLC — 0.15%

Which institutional investors are buying Annovis Bio stock?

Within the last quarter, ANVS stock was bought by institutional investors including:
  1. Essex LLC
During the last year, these company insiders have bought Annovis Bio stock:
  1. Reid Mccarthy (Director)
  2. Claudine Bruck (Director)
  3. Maria-Luisa Maccecchini (CEO)
Charles Payne reveals his market-beating strategy
You can learn how the best on Fox Business makes his decisions… see his portfolio and how he analyzes new opportunities.
Reserve Your Free eTicket Now